In this clinical comment, clinical nurse specialist Paul Beland reflects on his experiences as a living kidney donor.
AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
Addresses the significant threat of antimicrobial resistance.
The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.
This randomized, open-label trial evaluated aztreonam-avibactam plus metronidazole versus meropenem with or without colistin in patients with complicated intra-abdominal infections, or hospital ...
GlobalData on MSN15h
FDA approves AbbVie’s Emblaveo for intra-abdominal infectionsAbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
Approval of this indication is based on limited clinical safety and efficacy data for Emblaveo. In REVISIT, study participants with cIAI (n=312) were randomly assigned 2:1 to receive aztreonam ...
Here’s how it works. Space can be a wondrous place, and we've got the pictures to prove it! Take a look at our favorite space pictures here, and if you're wondering what happened to today in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback